Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

3ntmedical.com

Stage

Corporate Minority | Alive

Total Raised

$15M

Last Raised

$15M | 4 yrs ago

About 3NT Medical

3NT Medical develops endoscopic devices for ear, nose, and throat surgeons.

3NT Medical Headquarters Location

22 HaMelacha St Building 3, Entrance B

Rosh HaAyin, 4809169,

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing 3NT Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

3NT Medical is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,578 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

3NT Medical Patents

3NT Medical has filed 10 patents.

The 3 most popular patent topics include:

  • Surgical removal procedures
  • Medical equipment
  • Surgical instruments
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/6/2017

12/28/2021

Medical equipment, Endoscopy, Surgical instruments, Surgery, Surgical removal procedures

Grant

Application Date

6/6/2017

Grant Date

12/28/2021

Title

Related Topics

Medical equipment, Endoscopy, Surgical instruments, Surgery, Surgical removal procedures

Status

Grant

Latest 3NT Medical News

FDA approves 3NT Medical’s single-use sinus endoscope

Aug 12, 2021

12 Aug 2021 (Last Updated August 12th, 2021 09:45) The Peregrine Drivable ENT Scope can aid surgeons in angulating the 2.3mm tip and proceeding further. Share Article The Peregrine Drivable ENT Scope provides ENT surgeons with access to the furthest reaches of the sinuses. Credit: 3NT Medical. The US Food and Drug Administration (FDA) has granted clearance to 3NT Medical’s Peregrine Drivable ENT Scope, which can offer a high-quality view of the sinus anatomy for ear, nose and throat (ENT) surgical procedures. The anterior and lateral walls of the maxillary sinus, as well as the frontal sinus’ superior and lateral aspects, are hard to reach using endoscopes. This makes it hard for ENT surgeons to access and visualise deep within the sinuses. 3NT Medical’s Peregrine scope gives ENT surgeons the ability to reach the farthest areas of the sinuses and picturise anatomic landmarks closely, with greater image quality and lower levels of resection, both intra- and post-operatively. These benefits are accomplished using new mechanics, which aid surgeons in sharply angulating the Peregrine’s 2.3mm tip and proceeding further towards the turn, all during single-hand operation. Furthermore, the device can be used together with the standard 0° rigid endoscope or as the key endoscope in the operating room. Peregrine can be connected to a reduced-footprint video console, which reduces requirements for huge and high-priced endoscopy towers typically needed for standard endoscopes. The new single-use sterile device can also boost safety for patients as well as medical staff by eradicating cross-contamination risk. This could lower costs by reducing the sterilisation needs that are required for standard capital endoscopes. 3NT Medical CEO Ehud Bendory said: “This new scope joins our commercially-available Colibri Micro ENT Scope for otologists and demonstrates that 3NT Medical is executing on its vision of creating a portfolio of endoscopes designed specifically for ENT use. “We designed Peregrine exclusively for ENT surgeons to enable a better surgical experience for them as they strive to provide better outcomes and an enhanced experience for their patients.” In a study, the 3NT Medical Peregrine showed the ability to offer a complete view of the frontal and sphenoid sinuses as well as a 97.1% view of the maxillary sinus, versus 45.3%, 53.3% and 39.4%, respectively, with 4mm rigid endoscopes ranging from 0° to 70°. Related Companies

3NT Medical Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

3NT Medical Rank

  • Where is 3NT Medical's headquarters?

    3NT Medical's headquarters is located at 22 HaMelacha St, Rosh HaAyin.

  • What is 3NT Medical's latest funding round?

    3NT Medical's latest funding round is Corporate Minority.

  • How much did 3NT Medical raise?

    3NT Medical raised a total of $15M.

  • Who are the investors of 3NT Medical?

    Investors of 3NT Medical include HOYA.

  • Who are 3NT Medical's competitors?

    Competitors of 3NT Medical include DSA.

You May Also Like

D
DSA

DSA develops the DSA Analyzer, a handheld breathalyzer intended for the detection of COVID-19.

Abbott Logo
Abbott

Abbott (NYSE: ABT) is a global healthcare company with a portfolio of science-based offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.